Bryn Pharma Announces Appointment of Sandy Loreaux as CEO :

RALEIGH, N.C.--(BUSINESS WIRE)--#anaphylaxis--Bryn Pharma LLC, a privately held pharmaceutical company dedicated to finding a better way for patients and caregivers to treat anaphylaxis, announced today that pharmaceutical industry veteran Sandy Loreaux has been appointed CEO, effective immediately. David Dworaczyk,...

Related Keywords

Temple University , Pennsylvania , United States , Philadelphia , Steven Hartman , David Dworaczyk , Michelle Lobel , Covis Pharma , Sandy Loreaux , Temple University School Of Pharmacy , Bryn Co , Head Of Market Access At Mallinckrodt Pharmaceuticals , Operations At Bausch Health , Bryn Pharma , Us Critical Care For Mallinckrodt Pharmaceuticals , Bryn Co Founder Michelle , Senior Vice President , General Manager , Market Access , Mallinckrodt Pharmaceuticals , Commercial Operations , Temple University School , Better Way ,